Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-005695
Filing Date
2023-04-10
Accepted
2023-04-10 17:14:56
Documents
68
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 10-Q cydy-20230228x10q.htm   iXBRL 10-Q 2410313
2 EX-31.1 cydy-20230228xex31d1.htm EX-31.1 9270
3 EX-31.2 cydy-20230228xex31d2.htm EX-31.2 9435
4 EX-32 cydy-20230228xex32.htm EX-32 6426
  Complete submission text file 0001558370-23-005695.txt   9026088

Data Files

Seq Description Document Type Size
5 EX-101.SCH cydy-20230228.xsd EX-101.SCH 68526
6 EX-101.CAL cydy-20230228_cal.xml EX-101.CAL 53934
7 EX-101.DEF cydy-20230228_def.xml EX-101.DEF 270904
8 EX-101.LAB cydy-20230228_lab.xml EX-101.LAB 468241
9 EX-101.PRE cydy-20230228_pre.xml EX-101.PRE 422851
62 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20230228x10q_htm.xml XML 1519715
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 23811789
SIC: 2834 Pharmaceutical Preparations